When formulated as an 111InCl solution, it can be used to bind antibodies, peptides, or other molecular targeted proteins or other molecules, typically using a chelate to bind the radionuclide (in this case 111In) to the targeting molecule during the radiosynthesis/ radiolabeling process, which is tailored to the desired product.
"FDA Label Document:Indium In-111 Chloride Sterile Solution". www.accessdata.fda.gov. Archived from the original on April 29, 2017. Retrieved 20 Aug 2018. https://web.archive.org/web/20170429204932/https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019841 ↩
Takács, S.; Tárkányi, F.; Hermanne, A. (Dec 2005). "Validation and upgrading of the recommended cross-section data of charged particle reactions: Gamma emitter radioisotopes". Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. 240 (4): 790–802. Bibcode:2005NIMPB.240..790T. doi:10.1016/j.nimb.2005.06.209. ISSN 0168-583X. /wiki/Bibcode_(identifier) ↩
"Pentetoreotide". National Center for Biotechnology Information. 7 June 2025. https://pubchem.ncbi.nlm.nih.gov/compound/636392 ↩
"PubChem In-111 Oxyquinoline". pubchem.ncbi.nlm.nih.gov. Retrieved 20 Aug 2018. https://pubchem.ncbi.nlm.nih.gov/compound/119117#section=3D-Conformer ↩
"IN-111 FACT SHEET" (PDF). Nordion(Canada), Inc. Archived from the original (PDF) on 3 December 2011. Retrieved 23 September 2012. https://web.archive.org/web/20111203082605/http://www.nordion.com/documents/products/In-111_Can.pdf ↩